SCHEMBL7670960

SCHEMBL7670960

CCOC(=O)c1ccc2nc(O)n(Cc3ccc(Cl)cc3Cl)c2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.52
LMNA P02545 3/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
PDE2A O00408 2/20 0.46
PDE10A Q9Y233 1/20 0.46
SIRT2 Q8IXJ6 1/20 0.45
SIRT1 Q96EB6 1/20 0.45
SIRT3 Q9NTG7 1/20 0.45
ALDH1A1 P00352 3/20 0.44
KDM4E B2RXH2 2/20 0.44
ADORA2A P29274 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
VDR P11473 1/20 0.43
PKM P14618 1/20 0.42
MAPT P10636 2/20 0.42
NPC1 O15118 1/20 0.42
POLB P06746 1/20 0.42
TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173254 0.91 PPARG (0.62) PPARGLMNASMN1; SMN2PDE2APDE10A
SCHEMBL6301504 0.88 PPARG (0.51) PPARGLMNASMN1; SMN2PDE2APDE10A
SCHEMBL6170166 0.86 PPARG (0.49) PPARGLMNASMN1; SMN2PDE2APDE10A
SCHEMBL7676515 0.85 PPARG (0.55) PPARGLMNASMN1; SMN2PDE2APDE10A
SCHEMBL6168862 0.85 PDE2A (0.44) PPARGLMNASMN1; SMN2PDE2APDE10A
SCHEMBL6171260 0.84 DRD2 (0.52) PPARGLMNASMN1; SMN2PDE2APDE10A
SCHEMBL6301170 0.83 PPARG (0.52) PPARGLMNASMN1; SMN2PDE2APDE10A
SCHEMBL6213550 0.82 PPARG (0.51) PPARGLMNASMN1; SMN2PDE2APDE10A
SCHEMBL6168839 0.82 KDM4E (0.54) PPARGLMNASMN1; SMN2SIRT2SIRT1
SCHEMBL6308856 0.81 PPARG (0.52) PPARGPDE2APDE10ASIRT2SIRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6352985-B1 CARDIOVASCULAR DISORDERS OR GASTROINTESTINAL DISORDERS, DIABETES (TYPE II DIABETES), DIABETIC COMPLICATIONS METHOD FOR LOWERING THE BLOOD SUGAR LEVEL OF A PATIENT, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-05 US disclosed
US-6166219-A Benzimidazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-12-26 US disclosed
EP-0882718-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-09 EP disclosed